BindingDB logo
myBDB logout

Patent code US11034698

Compile Data Set for Download or QSAR
Found 115 hits of Enzyme Inhibition Constant Data   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504229
PNG
(N-[2-[(2R)-2-Fluoro-3-hydroxy- 3-methyl-butyl]-6-i...)
Show SMILES CC(C)Oc1cc2C(=O)N(C[C@@H](F)C(C)(C)O)Cc2cc1NC(=O)c1cnn2cccnc12
Show InChI InChI=1S/C23H26FN5O4/c1-13(2)33-18-9-15-14(11-28(22(15)31)12-19(24)23(3,4)32)8-17(18)27-21(30)16-10-26-29-7-5-6-25-20(16)29/h5-10,13,19,32H,11-12H2,1-4H3,(H,27,30)/t19-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
0.170n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504219
PNG
((R)-N-(6-(2,2-Difluoroethoxy)- 2-(2-fluoro-3-hydro...)
Show SMILES CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(OCC(F)F)cc2C1=O
Show InChI InChI=1S/C22H22F3N5O4/c1-22(2,33)17(23)10-29-9-12-6-15(16(34-11-18(24)25)7-13(12)21(29)32)28-20(31)14-8-27-30-5-3-4-26-19(14)30/h3-8,17-18,33H,9-11H2,1-2H3,(H,28,31)/t17-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
0.260n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504215
PNG
(N-[6-(3-Fluorocyclobutoxy)-2- [(2R)-2-fluoro-3-hyd...)
Show SMILES CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(O[C@@H]3C[C@H](F)C3)cc2C1=O
Show InChI InChI=1S/C24H25F2N5O4/c1-24(2,34)20(26)12-30-11-13-6-18(19(9-16(13)23(30)33)35-15-7-14(25)8-15)29-22(32)17-10-28-31-5-3-4-27-21(17)31/h3-6,9-10,14-15,20,34H,7-8,11-12H2,1-2H3,(H,29,32)/t14-,15+,20-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
0.280n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504233
PNG
((R)-N-(6-Ethoxy-2-(2-fluoro-3- hydroxy-3-methylbut...)
Show SMILES CCOc1cc2C(=O)N(C[C@@H](F)C(C)(C)O)Cc2cc1NC(=O)c1cnn2cccnc12
Show InChI InChI=1S/C22H24FN5O4/c1-4-32-17-9-14-13(11-27(21(14)30)12-18(23)22(2,3)31)8-16(17)26-20(29)15-10-25-28-7-5-6-24-19(15)28/h5-10,18,31H,4,11-12H2,1-3H3,(H,26,29)/t18-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
0.370n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504232
PNG
((R)-N-(2-(2-Fluoro-3-hydroxy- 3-methylbutyl)-6-iso...)
Show SMILES CC(C)Oc1cc2C(=O)N(C[C@@H](F)C(C)(C)O)Cc2cc1NC(=O)c1cnn2cc(C)cnc12
Show InChI InChI=1S/C24H28FN5O4/c1-13(2)34-19-7-16-15(11-29(23(16)32)12-20(25)24(4,5)33)6-18(19)28-22(31)17-9-27-30-10-14(3)8-26-21(17)30/h6-10,13,20,33H,11-12H2,1-5H3,(H,28,31)/t20-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
0.420n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504234
PNG
(US11034698, Example 83 | US11034698, Example 84)
Show SMILES CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(O[C@@H]3CCOC3)cc2C1=O
Show InChI InChI=1S/C24H26FN5O5/c1-24(2,33)20(25)12-29-11-14-8-18(19(9-16(14)23(29)32)35-15-4-7-34-13-15)28-22(31)17-10-27-30-6-3-5-26-21(17)30/h3,5-6,8-10,15,20,33H,4,7,11-13H2,1-2H3,(H,28,31)/t15-,20-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
0.490n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504239
PNG
((R)-N-(6-(Difluoromethoxy)-2- (2-fluoro-3-hydroxy-...)
Show SMILES CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(OC(F)F)cc2C1=O
Show InChI InChI=1S/C21H20F3N5O4/c1-21(2,32)16(22)10-28-9-11-6-14(15(33-20(23)24)7-12(11)19(28)31)27-18(30)13-8-26-29-5-3-4-25-17(13)29/h3-8,16,20,32H,9-10H2,1-2H3,(H,27,30)/t16-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
0.5n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504218
PNG
(N-[6-(3-Chlorocyclobutoxy)-2- [(2R)-2-fluoro-3-hyd...)
Show SMILES CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(O[C@@H]3C[C@H](Cl)C3)cc2C1=O
Show InChI InChI=1S/C24H25ClFN5O4/c1-24(2,34)20(26)12-30-11-13-6-18(19(9-16(13)23(30)33)35-15-7-14(25)8-15)29-22(32)17-10-28-31-5-3-4-27-21(17)31/h3-6,9-10,14-15,20,34H,7-8,11-12H2,1-2H3,(H,29,32)/t14-,15+,20-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
0.510n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504238
PNG
((R)-N-(2-(2-Fluoro-3-hydroxy- 3-methylbutyl)-6-(ox...)
Show SMILES CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(OC3COC3)cc2C1=O
Show InChI InChI=1S/C23H24FN5O5/c1-23(2,32)19(24)10-28-9-13-6-17(18(7-15(13)22(28)31)34-14-11-33-12-14)27-21(30)16-8-26-29-5-3-4-25-20(16)29/h3-8,14,19,32H,9-12H2,1-2H3,(H,27,30)/t19-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
0.590n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504241
PNG
((R)-N-(6-(tert-Butoxy)-2-(2- fluoro-3-hydroxy-3- m...)
Show SMILES CC(C)(C)Oc1cc2C(=O)N(C[C@@H](F)C(C)(C)O)Cc2cc1NC(=O)c1cnn2cccnc12
Show InChI InChI=1S/C24H28FN5O4/c1-23(2,3)34-18-10-15-14(12-29(22(15)32)13-19(25)24(4,5)33)9-17(18)28-21(31)16-11-27-30-8-6-7-26-20(16)30/h6-11,19,33H,12-13H2,1-5H3,(H,28,31)/t19-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
0.610n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504228
PNG
((R)-N-(6-Cyclopropoxy-2-(2- fluoro-3-hydroxy-3- me...)
Show SMILES CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(OC3CC3)cc2C1=O
Show InChI InChI=1S/C23H24FN5O4/c1-23(2,32)19(24)12-28-11-13-8-17(18(33-14-4-5-14)9-15(13)22(28)31)27-21(30)16-10-26-29-7-3-6-25-20(16)29/h3,6-10,14,19,32H,4-5,11-12H2,1-2H3,(H,27,30)/t19-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
0.630n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504267
PNG
((R)-N-(2-(2-Fluoro-3-hydroxy- 3-methylbutyl)-1-oxo...)
Show SMILES CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(OCC(F)(F)F)cc2C1=O
Show InChI InChI=1S/C22H21F4N5O4/c1-21(2,34)17(23)10-30-9-12-6-15(16(7-13(12)20(30)33)35-11-22(24,25)26)29-19(32)14-8-28-31-5-3-4-27-18(14)31/h3-8,17,34H,9-11H2,1-2H3,(H,29,32)/t17-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
0.630n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504220
PNG
(US11034698, Example 66 | US11034698, Example 67)
Show SMILES CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(O[C@H]3CC[C@@H](O)C3)cc2C1=O
Show InChI InChI=1S/C25H28FN5O5/c1-25(2,35)21(26)13-30-12-14-8-19(29-23(33)18-11-28-31-7-3-6-27-22(18)31)20(10-17(14)24(30)34)36-16-5-4-15(32)9-16/h3,6-8,10-11,15-16,21,32,35H,4-5,9,12-13H2,1-2H3,(H,29,33)/t15-,16+,21-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
0.670n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504224
PNG
((R)-N-(2-(2-Fluoro-3-hydroxy- 3-methylbutyl)-1-oxo...)
Show SMILES CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(OC3CCNCC3)cc2C1=O
Show InChI InChI=1S/C25H29FN6O4/c1-25(2,35)21(26)14-31-13-15-10-19(30-23(33)18-12-29-32-9-3-6-28-22(18)32)20(11-17(15)24(31)34)36-16-4-7-27-8-5-16/h3,6,9-12,16,21,27,35H,4-5,7-8,13-14H2,1-2H3,(H,30,33)/t21-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
0.700n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504234
PNG
(US11034698, Example 83 | US11034698, Example 84)
Show SMILES CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(O[C@@H]3CCOC3)cc2C1=O
Show InChI InChI=1S/C24H26FN5O5/c1-24(2,33)20(25)12-29-11-14-8-18(19(9-16(14)23(29)32)35-15-4-7-34-13-15)28-22(31)17-10-27-30-6-3-5-26-21(17)30/h3,5-6,8-10,15,20,33H,4,7,11-13H2,1-2H3,(H,28,31)/t15-,20-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
0.710n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504202
PNG
((R)-N-(6-Methoxy-2,2-dimethyl- 2,3-dihydrobenzofur...)
Show SMILES COc1cc2OC(C)(C)Cc2cc1NC(=O)c1cnn2ccc(N[C@@H]3CCCNC3)nc12
Show InChI InChI=1S/C23H28N6O3/c1-23(2)11-14-9-17(19(31-3)10-18(14)32-23)27-22(30)16-13-25-29-8-6-20(28-21(16)29)26-15-5-4-7-24-12-15/h6,8-10,13,15,24H,4-5,7,11-12H2,1-3H3,(H,26,28)(H,27,30)/t15-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
0.870n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504231
PNG
((R)-N-(6-(Cyclopentyloxy)-2-(2- fluoro-3-hydroxy-3...)
Show SMILES CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(OC3CCCC3)cc2C1=O
Show InChI InChI=1S/C25H28FN5O4/c1-25(2,34)21(26)14-30-13-15-10-19(20(11-17(15)24(30)33)35-16-6-3-4-7-16)29-23(32)18-12-28-31-9-5-8-27-22(18)31/h5,8-12,16,21,34H,3-4,6-7,13-14H2,1-2H3,(H,29,32)/t21-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
0.970n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504230
PNG
((R)-N-(2-(2-Fluoro-3-hydroxy- 3-methylbutyl)-6-(ox...)
Show SMILES CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(OCC3COC3)cc2C1=O
Show InChI InChI=1S/C24H26FN5O5/c1-24(2,33)20(25)10-29-9-15-6-18(19(7-16(15)23(29)32)35-13-14-11-34-12-14)28-22(31)17-8-27-30-5-3-4-26-21(17)30/h3-8,14,20,33H,9-13H2,1-2H3,(H,28,31)/t20-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
0.970n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504225
PNG
(US11034698, Example 71 | US11034698, Example 72)
Show SMILES CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(OC[C@@H]3CNC(=O)C3)cc2C1=O
Show InChI InChI=1S/C25H27FN6O5/c1-25(2,36)20(26)12-31-11-15-7-18(30-23(34)17-10-29-32-5-3-4-27-22(17)32)19(8-16(15)24(31)35)37-13-14-6-21(33)28-9-14/h3-5,7-8,10,14,20,36H,6,9,11-13H2,1-2H3,(H,28,33)(H,30,34)/t14-,20+/m0/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
1n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504214
PNG
((R)-N-(2-(2-Fluoro-3-hydroxy- 3-methylbutyl)-6-((1...)
Show SMILES Cn1cc(COc2cc3C(=O)N(C[C@@H](F)C(C)(C)O)Cc3cc2NC(=O)c2cnn3cccnc23)cn1
Show InChI InChI=1S/C25H26FN7O4/c1-25(2,36)21(26)13-32-12-16-7-19(30-23(34)18-10-29-33-6-4-5-27-22(18)33)20(8-17(16)24(32)35)37-14-15-9-28-31(3)11-15/h4-11,21,36H,12-14H2,1-3H3,(H,30,34)/t21-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
1.10n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504220
PNG
(US11034698, Example 66 | US11034698, Example 67)
Show SMILES CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(O[C@H]3CC[C@@H](O)C3)cc2C1=O
Show InChI InChI=1S/C25H28FN5O5/c1-25(2,35)21(26)13-30-12-14-8-19(29-23(33)18-11-28-31-7-3-6-27-22(18)31)20(10-17(14)24(30)34)36-16-5-4-15(32)9-16/h3,6-8,10-11,15-16,21,32,35H,4-5,9,12-13H2,1-2H3,(H,29,33)/t15-,16+,21-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
1.10n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504240
PNG
((R)-N-(2-(2-Fluoro-3-hydroxy- 3-methylbutyl)-6-((1...)
Show SMILES Cn1cc(Oc2cc3C(=O)N(C[C@@H](F)C(C)(C)O)Cc3cc2NC(=O)c2cnn3cccnc23)cn1
Show InChI InChI=1S/C24H24FN7O4/c1-24(2,35)20(25)13-31-11-14-7-18(29-22(33)17-10-28-32-6-4-5-26-21(17)32)19(8-16(14)23(31)34)36-15-9-27-30(3)12-15/h4-10,12,20,35H,11,13H2,1-3H3,(H,29,33)/t20-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
1.30n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504237
PNG
((R)-N-(2-(2-Fluoro-3-hydroxy- 3-methylbutyl)-6-met...)
Show SMILES COc1cc2C(=O)N(C[C@@H](F)C(C)(C)O)Cc2cc1NC(=O)c1cnn2cccnc12
Show InChI InChI=1S/C21H22FN5O4/c1-21(2,30)17(22)11-26-10-12-7-15(16(31-3)8-13(12)20(26)29)25-19(28)14-9-24-27-6-4-5-23-18(14)27/h4-9,17,30H,10-11H2,1-3H3,(H,25,28)/t17-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
1.30n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504258
PNG
(N-(2-((R)-2-Fluoro-3-hydroxy- 3-methylbutyl)-6-((7...)
Show SMILES CO[C@H]1C[C@@H]2CN(CCN2C1)c1cc2C(=O)N(C[C@@H](F)C(C)(C)O)Cc2cc1NC(=O)c1cnn2cccnc12
Show InChI InChI=1S/C28H34FN7O4/c1-28(2,39)24(29)16-35-13-17-9-22(32-26(37)21-12-31-36-6-4-5-30-25(21)36)23(11-20(17)27(35)38)34-8-7-33-15-19(40-3)10-18(33)14-34/h4-6,9,11-12,18-19,24,39H,7-8,10,13-16H2,1-3H3,(H,32,37)/t18-,19+,24-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
1.30n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504247
PNG
((R)-N-(6-(4-(2,2- Difluoroethyl)piperidin-1-yl)-2-...)
Show SMILES CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(cc2C1=O)N1CCC(CC(F)F)CC1
Show InChI InChI=1S/C27H31F3N6O3/c1-27(2,39)22(28)15-35-14-17-11-20(33-25(37)19-13-32-36-7-3-6-31-24(19)36)21(12-18(17)26(35)38)34-8-4-16(5-9-34)10-23(29)30/h3,6-7,11-13,16,22-23,39H,4-5,8-10,14-15H2,1-2H3,(H,33,37)/t22-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
1.5n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504222
PNG
(US11034698, Example 68 | US11034698, Example 69)
Show SMILES CC(C)Oc1cc2C(=O)N(Cc2cc1NC(=O)c1cnn2cccnc12)[C@H]1CCOC1
Show InChI InChI=1S/C22H23N5O4/c1-13(2)31-19-9-16-14(11-26(22(16)29)15-4-7-30-12-15)8-18(19)25-21(28)17-10-24-27-6-3-5-23-20(17)27/h3,5-6,8-10,13,15H,4,7,11-12H2,1-2H3,(H,25,28)/t15-/m0/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
1.80n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504250
PNG
(N-(2-((R)-2-Fluoro-3-hydroxy- 3-methylbutyl)-6-((R...)
Show SMILES CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(cc2C1=O)N1CCN2CCC[C@@H]2C1
Show InChI InChI=1S/C27H32FN7O3/c1-27(2,38)23(28)16-34-14-17-11-21(31-25(36)20-13-30-35-8-4-6-29-24(20)35)22(12-19(17)26(34)37)33-10-9-32-7-3-5-18(32)15-33/h4,6,8,11-13,18,23,38H,3,5,7,9-10,14-16H2,1-2H3,(H,31,36)/t18-,23-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
1.80n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504236
PNG
((R)-N-(2-(2-Fluoro-3-hydroxy- 3-methylbutyl)-1-oxo...)
Show SMILES CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(OC3CCOCC3)cc2C1=O
Show InChI InChI=1S/C25H28FN5O5/c1-25(2,34)21(26)14-30-13-15-10-19(29-23(32)18-12-28-31-7-3-6-27-22(18)31)20(11-17(15)24(30)33)36-16-4-8-35-9-5-16/h3,6-7,10-12,16,21,34H,4-5,8-9,13-14H2,1-2H3,(H,29,32)/t21-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
1.80n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504246
PNG
(N-[6-(Dimethylamino)-2- isopropyl-1-oxo-isoindolin...)
Show SMILES CC(C)N1Cc2cc(NC(=O)c3cnn4cccnc34)c(cc2C1=O)N(C)C
Show InChI InChI=1S/C20H22N6O2/c1-12(2)25-11-13-8-16(17(24(3)4)9-14(13)20(25)28)23-19(27)15-10-22-26-7-5-6-21-18(15)26/h5-10,12H,11H2,1-4H3,(H,23,27)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
1.90n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504256
PNG
((R)-N-(6-(4-(2-(1H-Imidazol-1- yl)ethyl)piperazin-...)
Show SMILES CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(cc2C1=O)N1CCN(CCn2ccnc2)CC1
Show InChI InChI=1S/C29H34FN9O3/c1-29(2,42)25(30)18-38-17-20-14-23(34-27(40)22-16-33-39-6-3-4-32-26(22)39)24(15-21(20)28(38)41)37-12-10-35(11-13-37)8-9-36-7-5-31-19-36/h3-7,14-16,19,25,42H,8-13,17-18H2,1-2H3,(H,34,40)/t25-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
2.10n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504173
PNG
(N-(6-(4-((4-Chloro-1H- imidazol-5-yl)methyl)pipera...)
Show SMILES CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(cc2O1)N1CCN(Cc2[nH]cnc2Cl)CC1
Show InChI InChI=1S/C25H27ClN8O2/c1-25(2)12-16-10-18(31-24(35)17-13-30-34-5-3-4-27-23(17)34)20(11-21(16)36-25)33-8-6-32(7-9-33)14-19-22(26)29-15-28-19/h3-5,10-11,13,15H,6-9,12,14H2,1-2H3,(H,28,29)(H,31,35)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
2.30n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504222
PNG
(US11034698, Example 68 | US11034698, Example 69)
Show SMILES CC(C)Oc1cc2C(=O)N(Cc2cc1NC(=O)c1cnn2cccnc12)[C@H]1CCOC1
Show InChI InChI=1S/C22H23N5O4/c1-13(2)31-19-9-16-14(11-26(22(16)29)15-4-7-30-12-15)8-18(19)25-21(28)17-10-24-27-6-3-5-23-20(17)27/h3,5-6,8-10,13,15H,4,7,11-12H2,1-2H3,(H,25,28)/t15-/m0/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
2.5n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504262
PNG
((R)-N-(2-(2-Fluoro-3-hydroxy- 3-methylbutyl)-6-(4-...)
Show SMILES COCCN1CCN(CC1)c1cc2C(=O)N(C[C@@H](F)C(C)(C)O)Cc2cc1NC(=O)c1cnn2cccnc12
Show InChI InChI=1S/C27H34FN7O4/c1-27(2,38)23(28)17-34-16-18-13-21(31-25(36)20-15-30-35-6-4-5-29-24(20)35)22(14-19(18)26(34)37)33-9-7-32(8-10-33)11-12-39-3/h4-6,13-15,23,38H,7-12,16-17H2,1-3H3,(H,31,36)/t23-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
2.60n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504259
PNG
((R)-N-(2-(2-Fluoro-3-hydroxy- 3-methylbutyl)-1-oxo...)
Show SMILES CC(F)(F)CN1CCN(CC1)c1cc2C(=O)N(C[C@@H](F)C(C)(C)O)Cc2cc1NC(=O)c1cnn2cccnc12
Show InChI InChI=1S/C27H32F3N7O3/c1-26(2,40)22(28)15-36-14-17-11-20(33-24(38)19-13-32-37-6-4-5-31-23(19)37)21(12-18(17)25(36)39)35-9-7-34(8-10-35)16-27(3,29)30/h4-6,11-13,22,40H,7-10,14-16H2,1-3H3,(H,33,38)/t22-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
2.60n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504205
PNG
(5-((2-Aminoethyl)amino)-N-(6- methoxy-2,2-dimethyl...)
Show SMILES COc1cc2OC(C)(C)Cc2cc1NC(=O)c1cnn2ccc(NCCN)nc12
Show InChI InChI=1S/C20H24N6O3/c1-20(2)10-12-8-14(16(28-3)9-15(12)29-20)24-19(27)13-11-23-26-7-4-17(22-6-5-21)25-18(13)26/h4,7-9,11H,5-6,10,21H2,1-3H3,(H,22,25)(H,24,27)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
3.20n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504225
PNG
(US11034698, Example 71 | US11034698, Example 72)
Show SMILES CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(OC[C@@H]3CNC(=O)C3)cc2C1=O
Show InChI InChI=1S/C25H27FN6O5/c1-25(2,36)20(26)12-31-11-15-7-18(30-23(34)17-10-29-32-5-3-4-27-22(17)32)19(8-16(15)24(31)35)37-13-14-6-21(33)28-9-14/h3-5,7-8,10,14,20,36H,6,9,11-13H2,1-2H3,(H,28,33)(H,30,34)/t14-,20+/m0/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
3.20n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM50511348
PNG
(CHEMBL4566431 | US11034698, Example 105)
Show SMILES CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(cc2C1=O)N1CCN(CC1)C1COC1
Show InChI InChI=1S/C27H32FN7O4/c1-27(2,38)23(28)14-34-13-17-10-21(31-25(36)20-12-30-35-5-3-4-29-24(20)35)22(11-19(17)26(34)37)33-8-6-32(7-9-33)18-15-39-16-18/h3-5,10-12,18,23,38H,6-9,13-16H2,1-2H3,(H,31,36)/t23-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
3.40n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM50511357
PNG
(CHEMBL4452765 | US11034698, Example 92)
Show SMILES O=C(Nc1cc2CN(CC3CCOCC3)C(=O)c2cc1N1CCOCC1)c1cnn2cccnc12
Show InChI InChI=1S/C25H28N6O4/c32-24(20-14-27-31-5-1-4-26-23(20)31)28-21-12-18-16-30(15-17-2-8-34-9-3-17)25(33)19(18)13-22(21)29-6-10-35-11-7-29/h1,4-5,12-14,17H,2-3,6-11,15-16H2,(H,28,32)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
3.70n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504227
PNG
(N-[6-(Azetidin-3-yloxy)-2- [(2R)-2-fluoro-3-hydrox...)
Show SMILES CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(OC3CNC3)cc2C1=O
Show InChI InChI=1S/C23H25FN6O4/c1-23(2,33)19(24)12-29-11-13-6-17(18(7-15(13)22(29)32)34-14-8-25-9-14)28-21(31)16-10-27-30-5-3-4-26-20(16)30/h3-7,10,14,19,25,33H,8-9,11-12H2,1-2H3,(H,28,31)/t19-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
3.70n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504166
PNG
(N-(6-(4-(2-Acetamidoethyl)piperazin-1-yl)-2,2-dime...)
Show SMILES CC(=O)NCCN1CCN(CC1)c1cc2OC(C)(C)Cc2cc1NC(=O)c1cnn2cccnc12
Show InChI InChI=1S/C25H31N7O3/c1-17(33)26-6-8-30-9-11-31(12-10-30)21-14-22-18(15-25(2,3)35-22)13-20(21)29-24(34)19-16-28-32-7-4-5-27-23(19)32/h4-5,7,13-14,16H,6,8-12,15H2,1-3H3,(H,26,33)(H,29,34)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
3.70n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504171
PNG
(N-[2,2-dimethyl-6-[4-[(4- methyl-1H-imidazol-5- yl...)
Show SMILES Cc1nc[nH]c1CN1CCN(CC1)c1cc2OC(C)(C)Cc2cc1NC(=O)c1cnn2cccnc12
Show InChI InChI=1S/C26H30N8O2/c1-17-21(29-16-28-17)15-32-7-9-33(10-8-32)22-12-23-18(13-26(2,3)36-23)11-20(22)31-25(35)19-14-30-34-6-4-5-27-24(19)34/h4-6,11-12,14,16H,7-10,13,15H2,1-3H3,(H,28,29)(H,31,35)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
3.80n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504172
PNG
(N-[6-[4-[(4-ethyl-1H-imidazol- 5-yl)methyl]piperaz...)
Show SMILES CCc1nc[nH]c1CN1CCN(CC1)c1cc2OC(C)(C)Cc2cc1NC(=O)c1cnn2cccnc12
Show InChI InChI=1S/C27H32N8O2/c1-4-20-22(30-17-29-20)16-33-8-10-34(11-9-33)23-13-24-18(14-27(2,3)37-24)12-21(23)32-26(36)19-15-31-35-7-5-6-28-25(19)35/h5-7,12-13,15,17H,4,8-11,14,16H2,1-3H3,(H,29,30)(H,32,36)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
3.90n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504201
PNG
((R)-5-(3-Aminopiperidin-1-yl)- N-(6-methoxy-2,2-di...)
Show SMILES COc1cc2OC(C)(C)Cc2cc1NC(=O)c1cnn2ccc(nc12)N1CCC[C@@H](N)C1
Show InChI InChI=1S/C23H28N6O3/c1-23(2)11-14-9-17(19(31-3)10-18(14)32-23)26-22(30)16-12-25-29-8-6-20(27-21(16)29)28-7-4-5-15(24)13-28/h6,8-10,12,15H,4-5,7,11,13,24H2,1-3H3,(H,26,30)/t15-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
4.10n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504174
PNG
(N-(2,2-Dimethyl-6-(4-((4- methylthiazol-5- yl)meth...)
Show SMILES Cc1ncsc1CN1CCN(CC1)c1cc2OC(C)(C)Cc2cc1NC(=O)c1cnn2cccnc12
Show InChI InChI=1S/C26H29N7O2S/c1-17-23(36-16-28-17)15-31-7-9-32(10-8-31)21-12-22-18(13-26(2,3)35-22)11-20(21)30-25(34)19-14-29-33-6-4-5-27-24(19)33/h4-6,11-12,14,16H,7-10,13,15H2,1-3H3,(H,30,34)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
4.60n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504203
PNG
(5-amino-N-(6-Methoxy-2,2- dimethyl-2,3- dihydroben...)
Show SMILES COc1cc2OC(C)(C)Cc2cc1NC(=O)c1cnn2ccc(N)nc12
Show InChI InChI=1S/C18H19N5O3/c1-18(2)8-10-6-12(14(25-3)7-13(10)26-18)21-17(24)11-9-20-23-5-4-15(19)22-16(11)23/h4-7,9H,8H2,1-3H3,(H2,19,22)(H,21,24)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
4.60n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504245
PNG
(N-[6-Morpholino-2-(2- oxaspiro[3,3]heptan-6-yl)-1-...)
Show SMILES O=C(Nc1cc2CN(C3CC4(COC4)C3)C(=O)c2cc1N1CCOCC1)c1cnn2cccnc12
Show InChI InChI=1S/C25H26N6O4/c32-23(19-12-27-31-3-1-2-26-22(19)31)28-20-8-16-13-30(17-10-25(11-17)14-35-15-25)24(33)18(16)9-21(20)29-4-6-34-7-5-29/h1-3,8-9,12,17H,4-7,10-11,13-15H2,(H,28,32)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
4.90n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504254
PNG
((R)-N-(6-(4-((3-Ethylisoxazol-4- yl)methyl)piperaz...)
Show SMILES CCc1nocc1CN1CCN(CC1)c1cc2C(=O)N(C[C@@H](F)C(C)(C)O)Cc2cc1NC(=O)c1cnn2cccnc12
Show InChI InChI=1S/C30H35FN8O4/c1-4-23-20(18-43-35-23)15-36-8-10-37(11-9-36)25-13-21-19(16-38(29(21)41)17-26(31)30(2,3)42)12-24(25)34-28(40)22-14-33-39-7-5-6-32-27(22)39/h5-7,12-14,18,26,42H,4,8-11,15-17H2,1-3H3,(H,34,40)/t26-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
5n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504165
PNG
(N-(2,2-Dimethyl-6-(4-(2- (methylsulfonamido)ethyl)...)
Show SMILES CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(cc2O1)N1CCN(CCNS(C)(=O)=O)CC1
Show InChI InChI=1S/C24H31N7O4S/c1-24(2)15-17-13-19(28-23(32)18-16-26-31-7-4-5-25-22(18)31)20(14-21(17)35-24)30-11-9-29(10-12-30)8-6-27-36(3,33)34/h4-5,7,13-14,16,27H,6,8-12,15H2,1-3H3,(H,28,32)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
5.10n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504248
PNG
(N-(6-Cyclopropyl-2-isopropyl- 1-oxoisoindolin-5- y...)
Show SMILES CC(C)N1Cc2cc(NC(=O)c3cnn4cccnc34)c(cc2C1=O)C1CC1
Show InChI InChI=1S/C21H21N5O2/c1-12(2)25-11-14-8-18(15(13-4-5-13)9-16(14)21(25)28)24-20(27)17-10-23-26-7-3-6-22-19(17)26/h3,6-10,12-13H,4-5,11H2,1-2H3,(H,24,27)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
5.20n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504175
PNG
(N-(2,2-Dimethyl-6-(4-((5- methylisoxazol-4- yl)met...)
Show SMILES Cc1oncc1CN1CCN(CC1)c1cc2OC(C)(C)Cc2cc1NC(=O)c1cnn2cccnc12
Show InChI InChI=1S/C26H29N7O3/c1-17-19(14-29-36-17)16-31-7-9-32(10-8-31)22-12-23-18(13-26(2,3)35-23)11-21(22)30-25(34)20-15-28-33-6-4-5-27-24(20)33/h4-6,11-12,14-15H,7-10,13,16H2,1-3H3,(H,30,34)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
5.20n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504177
PNG
(N-(2,2-Dimethyl-6-(4-((3- methylisoxazol-4- yl)met...)
Show SMILES Cc1nocc1CN1CCN(CC1)c1cc2OC(C)(C)Cc2cc1NC(=O)c1cnn2cccnc12
Show InChI InChI=1S/C26H29N7O3/c1-17-19(16-35-30-17)15-31-7-9-32(10-8-31)22-12-23-18(13-26(2,3)36-23)11-21(22)29-25(34)20-14-28-33-6-4-5-27-24(20)33/h4-6,11-12,14,16H,7-10,13,15H2,1-3H3,(H,29,34)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
5.20n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504169
PNG
(US11034698, Example 6 | US11034698, Example 7)
Show SMILES CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(cc2O1)N1CCN(C[C@@H]2CCCC(=O)N2)CC1
Show InChI InChI=1S/C27H33N7O3/c1-27(2)15-18-13-21(31-26(36)20-16-29-34-8-4-7-28-25(20)34)22(14-23(18)37-27)33-11-9-32(10-12-33)17-19-5-3-6-24(35)30-19/h4,7-8,13-14,16,19H,3,5-6,9-12,15,17H2,1-2H3,(H,30,35)(H,31,36)/t19-/m0/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
5.30n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504216
PNG
(US11034698, Example 62 | US11034698, Example 63)
Show SMILES CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(O[C@H]3CCNC3)cc2C1=O
Show InChI InChI=1S/C24H27FN6O4/c1-24(2,34)20(25)13-30-12-14-8-18(19(9-16(14)23(30)33)35-15-4-6-26-10-15)29-22(32)17-11-28-31-7-3-5-27-21(17)31/h3,5,7-9,11,15,20,26,34H,4,6,10,12-13H2,1-2H3,(H,29,32)/t15-,20+/m0/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
5.30n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504253
PNG
((R)-N-(6-(4-((5-Ethylisoxazol-4- yl)methyl)piperaz...)
Show SMILES CCc1oncc1CN1CCN(CC1)c1cc2C(=O)N(C[C@@H](F)C(C)(C)O)Cc2cc1NC(=O)c1cnn2cccnc12
Show InChI InChI=1S/C30H35FN8O4/c1-4-25-20(14-34-43-25)16-36-8-10-37(11-9-36)24-13-21-19(17-38(29(21)41)18-26(31)30(2,3)42)12-23(24)35-28(40)22-15-33-39-7-5-6-32-27(22)39/h5-7,12-15,26,42H,4,8-11,16-18H2,1-3H3,(H,35,40)/t26-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
5.40n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504266
PNG
((R)-N-(2-(2-Fluoro-3-hydroxy- 3-methylbutyl)-6-mor...)
Show SMILES CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cc(O)cnc34)c(cc2C1=O)N1CCOCC1
Show InChI InChI=1S/C24H27FN6O5/c1-24(2,35)20(25)13-30-11-14-7-18(19(8-16(14)23(30)34)29-3-5-36-6-4-29)28-22(33)17-10-27-31-12-15(32)9-26-21(17)31/h7-10,12,20,32,35H,3-6,11,13H2,1-2H3,(H,28,33)/t20-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
5.70n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504264
PNG
((R)-5-Acetamido-N-(6- (dimethylamino)-2-(2-fluoro-...)
Show SMILES CN(C)c1cc2C(=O)N(C[C@@H](F)C(C)(C)O)Cc2cc1NC(=O)c1cnn2ccc(NC(C)=O)nc12
Show InChI InChI=1S/C24H28FN7O4/c1-13(33)27-20-6-7-32-21(29-20)16(10-26-32)22(34)28-17-8-14-11-31(12-19(25)24(2,3)36)23(35)15(14)9-18(17)30(4)5/h6-10,19,36H,11-12H2,1-5H3,(H,28,34)(H,27,29,33)/t19-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
6.40n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504252
PNG
((R)-5-Chloro-N-(2-(2-fluoro-3- hydroxy-3-methylbut...)
Show SMILES CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4ccc(Cl)nc34)c(cc2C1=O)N1CCOCC1
Show InChI InChI=1S/C24H26ClFN6O4/c1-24(2,35)19(26)13-31-12-14-9-17(18(10-15(14)23(31)34)30-5-7-36-8-6-30)28-22(33)16-11-27-32-4-3-20(25)29-21(16)32/h3-4,9-11,19,35H,5-8,12-13H2,1-2H3,(H,28,33)/t19-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
6.5n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504257
PNG
(N-(2-((R)-2-Fluoro-3-hydroxy- 3-methylbutyl)-6-((7...)
Show SMILES CO[C@@H]1C[C@@H]2CN(CCN2C1)c1cc2C(=O)N(C[C@@H](F)C(C)(C)O)Cc2cc1NC(=O)c1cnn2cccnc12
Show InChI InChI=1S/C28H34FN7O4/c1-28(2,39)24(29)16-35-13-17-9-22(32-26(37)21-12-31-36-6-4-5-30-25(21)36)23(11-20(17)27(35)38)34-8-7-33-15-19(40-3)10-18(33)14-34/h4-6,9,11-12,18-19,24,39H,7-8,10,13-16H2,1-3H3,(H,32,37)/t18-,19-,24-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
6.5n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504180
PNG
(US11034698, Example 17 | US11034698, Example 18)
Show SMILES CC[C@@H]1CC(=O)NN1C1CCN(CC1)c1cc2OC(C)(C)Cc2cc1NC(=O)c1cnn2cccnc12
Show InChI InChI=1S/C27H33N7O3/c1-4-18-13-24(35)31-34(18)19-6-10-32(11-7-19)22-14-23-17(15-27(2,3)37-23)12-21(22)30-26(36)20-16-29-33-9-5-8-28-25(20)33/h5,8-9,12,14,16,18-19H,4,6-7,10-11,13,15H2,1-3H3,(H,30,36)(H,31,35)/t18-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
6.70n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504164
PNG
(N-[6-[4-(2- aminoethyl)piperazin-1-yl]-2,2- dimeth...)
Show SMILES CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(cc2O1)N1CCN(CCN)CC1
Show InChI InChI=1S/C23H29N7O2/c1-23(2)14-16-12-18(27-22(31)17-15-26-30-6-3-5-25-21(17)30)19(13-20(16)32-23)29-10-8-28(7-4-24)9-11-29/h3,5-6,12-13,15H,4,7-11,14,24H2,1-2H3,(H,27,31)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
7.40n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504260
PNG
(US11034698, Example 110 | US11034698, Example 111)
Show SMILES C[C@H]1C[C@@H]2CN(CCN2C1)c1cc2C(=O)N(C[C@@H](F)C(C)(C)O)Cc2cc1NC(=O)c1cnn2cccnc12
Show InChI InChI=1S/C28H34FN7O3/c1-17-9-19-15-34(8-7-33(19)13-17)23-11-20-18(14-35(27(20)38)16-24(29)28(2,3)39)10-22(23)32-26(37)21-12-31-36-6-4-5-30-25(21)36/h4-6,10-12,17,19,24,39H,7-9,13-16H2,1-3H3,(H,32,37)/t17-,19+,24+/m0/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
7.5n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504263
PNG
((R)-N-(2-(2-Fluoro-3-hydroxy-3- methylbutyl)-6-(4-...)
Show SMILES CC(C)N1CCN(CC1)c1cc2C(=O)N(C[C@@H](F)C(C)(C)O)Cc2cc1NC(=O)c1cnn2cccnc12
Show InChI InChI=1S/C27H34FN7O3/c1-17(2)32-8-10-33(11-9-32)22-13-19-18(15-34(26(19)37)16-23(28)27(3,4)38)12-21(22)31-25(36)20-14-30-35-7-5-6-29-24(20)35/h5-7,12-14,17,23,38H,8-11,15-16H2,1-4H3,(H,31,36)/t23-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
7.5n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504198
PNG
((S)-5-(5-Amino-3,3-difluoropiperidin-1-yl)-N-(6-me...)
Show SMILES COc1cc2OC(C)(C)Cc2cc1NC(=O)c1cnn2ccc(nc12)N1C[C@@H](N)CC(F)(F)C1
Show InChI InChI=1S/C23H26F2N6O3/c1-22(2)8-13-6-16(18(33-3)7-17(13)34-22)28-21(32)15-10-27-31-5-4-19(29-20(15)31)30-11-14(26)9-23(24,25)12-30/h4-7,10,14H,8-9,11-12,26H2,1-3H3,(H,28,32)/t14-/m0/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
7.70n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504269
PNG
((R)-N-(2-(2-Fluoro-3-hydroxy- 3-methylbutyl)-6-(5-...)
Show SMILES Cc1ccc(nc1)-c1cc2C(=O)N(C[C@@H](F)C(C)(C)O)Cc2cc1NC(=O)c1cnn2cccnc12
Show InChI InChI=1S/C26H25FN6O3/c1-15-5-6-20(29-11-15)18-10-17-16(13-32(25(17)35)14-22(27)26(2,3)36)9-21(18)31-24(34)19-12-30-33-8-4-7-28-23(19)33/h4-12,22,36H,13-14H2,1-3H3,(H,31,34)/t22-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
8.10n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504176
PNG
(N-(2,2-Dimethyl-6-(4-(oxetan-3- yl)piperazin-1-yl)...)
Show SMILES CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(cc2O1)N1CCN(CC1)C1COC1
Show InChI InChI=1S/C24H28N6O3/c1-24(2)12-16-10-19(27-23(31)18-13-26-30-5-3-4-25-22(18)30)20(11-21(16)33-24)29-8-6-28(7-9-29)17-14-32-15-17/h3-5,10-11,13,17H,6-9,12,14-15H2,1-2H3,(H,27,31)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
8.10n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504272
PNG
(N-(6-(Dimethylamino)-7- (hydroxymethyl)-2-isopropy...)
Show SMILES CC(C)N1Cc2cc(NC(=O)c3cnn4cccnc34)c(N(C)C)c(CO)c2C1=O
Show InChI InChI=1S/C21H24N6O3/c1-12(2)26-10-13-8-16(18(25(3)4)15(11-28)17(13)21(26)30)24-20(29)14-9-23-27-7-5-6-22-19(14)27/h5-9,12,28H,10-11H2,1-4H3,(H,24,29)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
8.20n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504180
PNG
(US11034698, Example 17 | US11034698, Example 18)
Show SMILES CC[C@@H]1CC(=O)NN1C1CCN(CC1)c1cc2OC(C)(C)Cc2cc1NC(=O)c1cnn2cccnc12
Show InChI InChI=1S/C27H33N7O3/c1-4-18-13-24(35)31-34(18)19-6-10-32(11-7-19)22-14-23-17(15-27(2,3)37-23)12-21(22)30-26(36)20-16-29-33-9-5-8-28-25(20)33/h5,8-9,12,14,16,18-19H,4,6-7,10-11,13,15H2,1-3H3,(H,30,36)(H,31,35)/t18-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
8.40n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504249
PNG
((R)-N-(6-Cyano-2-(2-fluoro-3- hydroxy-3-methylbuty...)
Show SMILES CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(cc2C1=O)C#N
Show InChI InChI=1S/C21H19FN6O3/c1-21(2,31)17(22)11-27-10-13-7-16(12(8-23)6-14(13)20(27)30)26-19(29)15-9-25-28-5-3-4-24-18(15)28/h3-7,9,17,31H,10-11H2,1-2H3,(H,26,29)/t17-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
8.5n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504216
PNG
(US11034698, Example 62 | US11034698, Example 63)
Show SMILES CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(O[C@H]3CCNC3)cc2C1=O
Show InChI InChI=1S/C24H27FN6O4/c1-24(2,34)20(25)13-30-12-14-8-18(19(9-16(14)23(30)33)35-15-4-6-26-10-15)29-22(32)17-11-28-31-7-3-5-27-21(17)31/h3,5,7-9,11,15,20,26,34H,4,6,10,12-13H2,1-2H3,(H,29,32)/t15-,20+/m0/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
9.20n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504178
PNG
(N-(6-(4-((5-Ethyl-2-oxo-2,3- dihydrooxazol-4- yl)m...)
Show SMILES CCc1oc(=O)[nH]c1CN1CCN(CC1)c1cc2OC(C)(C)Cc2cc1NC(=O)c1cnn2cccnc12
Show InChI InChI=1S/C27H31N7O4/c1-4-22-20(31-26(36)37-22)16-32-8-10-33(11-9-32)21-13-23-17(14-27(2,3)38-23)12-19(21)30-25(35)18-15-29-34-7-5-6-28-24(18)34/h5-7,12-13,15H,4,8-11,14,16H2,1-3H3,(H,30,35)(H,31,36)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
9.40n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504260
PNG
(US11034698, Example 110 | US11034698, Example 111)
Show SMILES C[C@H]1C[C@@H]2CN(CCN2C1)c1cc2C(=O)N(C[C@@H](F)C(C)(C)O)Cc2cc1NC(=O)c1cnn2cccnc12
Show InChI InChI=1S/C28H34FN7O3/c1-17-9-19-15-34(8-7-33(19)13-17)23-11-20-18(14-35(27(20)38)16-24(29)28(2,3)39)10-22(23)32-26(37)21-12-31-36-6-4-5-30-25(21)36/h4-6,10-12,17,19,24,39H,7-9,13-16H2,1-3H3,(H,32,37)/t17-,19+,24+/m0/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
9.90n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504169
PNG
(US11034698, Example 6 | US11034698, Example 7)
Show SMILES CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(cc2O1)N1CCN(C[C@@H]2CCCC(=O)N2)CC1
Show InChI InChI=1S/C27H33N7O3/c1-27(2)15-18-13-21(31-26(36)20-16-29-34-8-4-7-28-25(20)34)22(14-23(18)37-27)33-11-9-32(10-12-33)17-19-5-3-6-24(35)30-19/h4,7-8,13-14,16,19H,3,5-6,9-12,15,17H2,1-2H3,(H,30,35)(H,31,36)/t19-/m0/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
10n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504251
PNG
(N-(2-((R)-2-Fluoro-3-hydroxy- 3-methylbutyl)-6-((7...)
Show SMILES CO[C@@H]1C[C@H]2CN(CCN2C1)c1cc2C(=O)N(C[C@@H](F)C(C)(C)O)Cc2cc1NC(=O)c1cnn2cccnc12
Show InChI InChI=1S/C28H34FN7O4/c1-28(2,39)24(29)16-35-13-17-9-22(32-26(37)21-12-31-36-6-4-5-30-25(21)36)23(11-20(17)27(35)38)34-8-7-33-15-19(40-3)10-18(33)14-34/h4-6,9,11-12,18-19,24,39H,7-8,10,13-16H2,1-3H3,(H,32,37)/t18-,19+,24+/m0/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
12n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504179
PNG
(N-(6-(4-((3,5-Dimethylisoxazol- 4-yl)methyl)pipera...)
Show SMILES Cc1noc(C)c1CN1CCN(CC1)c1cc2OC(C)(C)Cc2cc1NC(=O)c1cnn2cccnc12
Show InChI InChI=1S/C27H31N7O3/c1-17-21(18(2)37-31-17)16-32-8-10-33(11-9-32)23-13-24-19(14-27(3,4)36-24)12-22(23)30-26(35)20-15-29-34-7-5-6-28-25(20)34/h5-7,12-13,15H,8-11,14,16H2,1-4H3,(H,30,35)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
14n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504198
PNG
((S)-5-(5-Amino-3,3-difluoropiperidin-1-yl)-N-(6-me...)
Show SMILES COc1cc2OC(C)(C)Cc2cc1NC(=O)c1cnn2ccc(nc12)N1C[C@@H](N)CC(F)(F)C1
Show InChI InChI=1S/C23H26F2N6O3/c1-22(2)8-13-6-16(18(33-3)7-17(13)34-22)28-21(32)15-10-27-31-5-4-19(29-20(15)31)30-11-14(26)9-23(24,25)12-30/h4-7,10,14H,8-9,11-12,26H2,1-3H3,(H,28,32)/t14-/m0/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
14n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504277
PNG
(US11034698, Example 156 | US11034698, Example 157)
Show SMILES CN(C)c1cc2[C@H](O)C(C)(C)Cc2cc1NC(=O)c1cnn2cccnc12
Show InChI InChI=1S/C20H23N5O2/c1-20(2)10-12-8-15(16(24(3)4)9-13(12)17(20)26)23-19(27)14-11-22-25-7-5-6-21-18(14)25/h5-9,11,17,26H,10H2,1-4H3,(H,23,27)/t17-/m0/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
16n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504271
PNG
((R)-N-(2-(2-Fluoro-3-hydroxy- 3-methylbutyl)-6-(2-...)
Show SMILES CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(cc2C1=O)C(C)(C)O
Show InChI InChI=1S/C23H26FN5O4/c1-22(2,32)16-9-14-13(11-28(21(14)31)12-18(24)23(3,4)33)8-17(16)27-20(30)15-10-26-29-7-5-6-25-19(15)29/h5-10,18,32-33H,11-12H2,1-4H3,(H,27,30)/t18-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
16n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504182
PNG
(N-(6-(((3S,4S)-4-Amino-1-(2-amino-2-oxoethyl)pyrro...)
Show SMILES CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(O[C@H]3CN(CC(N)=O)C[C@@H]3N)cc2O1
Show InChI InChI=1S/C23H27N7O4/c1-23(2)8-13-6-16(28-22(32)14-9-27-30-5-3-4-26-21(14)30)18(7-17(13)34-23)33-19-11-29(10-15(19)24)12-20(25)31/h3-7,9,15,19H,8,10-12,24H2,1-2H3,(H2,25,31)(H,28,32)/t15-,19-/m0/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
17n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504168
PNG
(N-[2,2-dimethyl-6-[4-[(3- methyl-6-oxo-1H-pyridin-...)
Show SMILES Cc1ccc(=O)[nH]c1CN1CCN(CC1)c1cc2OC(C)(C)Cc2cc1NC(=O)c1cnn2cccnc12
Show InChI InChI=1S/C28H31N7O3/c1-18-5-6-25(36)31-22(18)17-33-9-11-34(12-10-33)23-14-24-19(15-28(2,3)38-24)13-21(23)32-27(37)20-16-30-35-8-4-7-29-26(20)35/h4-8,13-14,16H,9-12,15,17H2,1-3H3,(H,31,36)(H,32,37)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
18n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504265
PNG
((R)-N5-Cyclopropyl-N3-(6- (dimethylamino)-2-(2-flu...)
Show SMILES CN(C)c1cc2C(=O)N(C[C@@H](F)C(C)(C)O)Cc2cc1NC(=O)c1cnn2ccc(nc12)C(=O)NC1CC1
Show InChI InChI=1S/C26H30FN7O4/c1-26(2,38)21(27)13-33-12-14-9-19(20(32(3)4)10-16(14)25(33)37)31-23(35)17-11-28-34-8-7-18(30-22(17)34)24(36)29-15-5-6-15/h7-11,15,21,38H,5-6,12-13H2,1-4H3,(H,29,36)(H,31,35)/t21-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
19n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504212
PNG
((R)—N-(3-(2-Cyanoethyl)-3-methyl-7-morpholino...)
Show SMILES C[C@@]1(CCC#N)COc2cc(N3CCOCC3)c(NC(=O)c3cnn4cccnc34)cc2C1
Show InChI InChI=1S/C24H26N6O3/c1-24(4-2-5-25)14-17-12-19(20(13-21(17)33-16-24)29-8-10-32-11-9-29)28-23(31)18-15-27-30-7-3-6-26-22(18)30/h3,6-7,12-13,15H,2,4,8-11,14,16H2,1H3,(H,28,31)/t24-/m0/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
19n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504244
PNG
(N-[6-Morpholino-1-oxo-2-(2- pyrrolidin-1-ylethyl)i...)
Show SMILES O=C(Nc1cc2CN(CCN3CCCC3)C(=O)c2cc1N1CCOCC1)c1cnn2cccnc12
Show InChI InChI=1S/C25H29N7O3/c33-24(20-16-27-32-7-3-4-26-23(20)32)28-21-14-18-17-31(9-8-29-5-1-2-6-29)25(34)19(18)15-22(21)30-10-12-35-13-11-30/h3-4,7,14-16H,1-2,5-6,8-13,17H2,(H,28,33)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
22n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504275
PNG
(US11034698, Example 154 | US11034698, Example 155)
Show SMILES CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(cc2[S@]1=O)N1CCOCC1
Show InChI InChI=1S/C21H23N5O3S/c1-21(2)12-14-10-16(17(11-18(14)30(21)28)25-6-8-29-9-7-25)24-20(27)15-13-23-26-5-3-4-22-19(15)26/h3-5,10-11,13H,6-9,12H2,1-2H3,(H,24,27)/t30-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
22n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504204
PNG
(N-(6-Methoxy-2,2-dimethyl-2,3- dihydrobenzofuran-5...)
Show SMILES COc1cc2OC(C)(C)Cc2cc1NC(=O)c1cnn2ccc(nc12)N1CCNCC1
Show InChI InChI=1S/C22H26N6O3/c1-22(2)12-14-10-16(18(30-3)11-17(14)31-22)25-21(29)15-13-24-28-7-4-19(26-20(15)28)27-8-5-23-6-9-27/h4,7,10-11,13,23H,5-6,8-9,12H2,1-3H3,(H,25,29)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
22n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504212
PNG
((R)—N-(3-(2-Cyanoethyl)-3-methyl-7-morpholino...)
Show SMILES C[C@@]1(CCC#N)COc2cc(N3CCOCC3)c(NC(=O)c3cnn4cccnc34)cc2C1
Show InChI InChI=1S/C24H26N6O3/c1-24(4-2-5-25)14-17-12-19(20(13-21(17)33-16-24)29-8-10-32-11-9-29)28-23(31)18-15-27-30-7-3-6-26-22(18)30/h3,6-7,12-13,15H,2,4,8-11,14,16H2,1H3,(H,28,31)/t24-/m0/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
30n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504167
PNG
(N-(6-(4-(2-(Dimethylamino)ethyl)piperazin-1-yl)-2,...)
Show SMILES CN(C)CCN1CCN(CC1)c1cc2OC(C)(C)Cc2cc1NC(=O)c1cnn2cccnc12
Show InChI InChI=1S/C25H33N7O2/c1-25(2)16-18-14-20(28-24(33)19-17-27-32-7-5-6-26-23(19)32)21(15-22(18)34-25)31-12-10-30(11-13-31)9-8-29(3)4/h5-7,14-15,17H,8-13,16H2,1-4H3,(H,28,33)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
41n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504208
PNG
(N-(7-Morpholino-2-oxo-1,2,3,4- tetrahydroquinolin-...)
Show SMILES O=C(Nc1cc2CCC(=O)Nc2cc1N1CCOCC1)c1cnn2cccnc12
Show InChI InChI=1S/C20H20N6O3/c27-18-3-2-13-10-16(17(11-15(13)23-18)25-6-8-29-9-7-25)24-20(28)14-12-22-26-5-1-4-21-19(14)26/h1,4-5,10-12H,2-3,6-9H2,(H,23,27)(H,24,28)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
42n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504270
PNG
(N-[2-[(2R)-2-Fluoro-3-hydroxy- 3-methyl-butyl]-6-(...)
Show SMILES CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(cc2C1=O)C1COC1
Show InChI InChI=1S/C23H24FN5O4/c1-23(2,32)19(24)10-28-9-13-6-18(15(14-11-33-12-14)7-16(13)22(28)31)27-21(30)17-8-26-29-5-3-4-25-20(17)29/h3-8,14,19,32H,9-12H2,1-2H3,(H,27,30)/t19-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
48n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504182
PNG
(N-(6-(((3S,4S)-4-Amino-1-(2-amino-2-oxoethyl)pyrro...)
Show SMILES CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(O[C@H]3CN(CC(N)=O)C[C@@H]3N)cc2O1
Show InChI InChI=1S/C23H27N7O4/c1-23(2)8-13-6-16(28-22(32)14-9-27-30-5-3-4-26-21(14)30)18(7-17(13)34-23)33-19-11-29(10-15(19)24)12-20(25)31/h3-7,9,15,19H,8,10-12,24H2,1-2H3,(H2,25,31)(H,28,32)/t15-,19-/m0/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
53n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504209
PNG
(N-(1-(2-Hydroxyethyl)-7- morpholino-2-oxo-1,2,3,4-...)
Show SMILES OCCN1C(=O)CCc2cc(NC(=O)c3cnn4cccnc34)c(cc12)N1CCOCC1
Show InChI InChI=1S/C22H24N6O4/c29-9-6-27-18-13-19(26-7-10-32-11-8-26)17(12-15(18)2-3-20(27)30)25-22(31)16-14-24-28-5-1-4-23-21(16)28/h1,4-5,12-14,29H,2-3,6-11H2,(H,25,31)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
53n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504193
PNG
(US11034698, Example 30 | US11034698, Example 31 | ...)
Show SMILES CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(OC[C@H]3C[C@@H]4NCCO[C@H]4C3)cc2O1
Show InChI InChI=1S/C25H29N5O4/c1-25(2)12-16-10-19(29-24(31)17-13-28-30-6-3-4-27-23(17)30)22(11-20(16)34-25)33-14-15-8-18-21(9-15)32-7-5-26-18/h3-4,6,10-11,13,15,18,21,26H,5,7-9,12,14H2,1-2H3,(H,29,31)/t15-,18-,21-/m0/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
60n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504268
PNG
(N-[2,2-Dimethyl-6-(5-methyl-2- pyridyl)-3H-benzofu...)
Show SMILES Cc1ccc(nc1)-c1cc2OC(C)(C)Cc2cc1NC(=O)c1cnn2cccnc12
Show InChI InChI=1S/C23H21N5O2/c1-14-5-6-18(25-12-14)16-10-20-15(11-23(2,3)30-20)9-19(16)27-22(29)17-13-26-28-8-4-7-24-21(17)28/h4-10,12-13H,11H2,1-3H3,(H,27,29)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
60n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504193
PNG
(US11034698, Example 30 | US11034698, Example 31 | ...)
Show SMILES CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(OC[C@H]3C[C@@H]4NCCO[C@H]4C3)cc2O1
Show InChI InChI=1S/C25H29N5O4/c1-25(2)12-16-10-19(29-24(31)17-13-28-30-6-3-4-27-23(17)30)22(11-20(16)34-25)33-14-15-8-18-21(9-15)32-7-5-26-18/h3-4,6,10-11,13,15,18,21,26H,5,7-9,12,14H2,1-2H3,(H,29,31)/t15-,18-,21-/m0/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
66n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504187
PNG
(US11034698, Example 24 | US11034698, Example 25)
Show SMILES CN1C[C@H](COc2cc3OC(C)(C)Cc3cc2NC(=O)c2cnn3cccnc23)CC1=O
Show InChI InChI=1S/C23H25N5O4/c1-23(2)10-15-8-17(26-22(30)16-11-25-28-6-4-5-24-21(16)28)19(9-18(15)32-23)31-13-14-7-20(29)27(3)12-14/h4-6,8-9,11,14H,7,10,12-13H2,1-3H3,(H,26,30)/t14-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
90n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504197
PNG
(N-(6-Methoxy-2,2-dimethyl-2,3- dihydrobenzofuran-5...)
Show SMILES COc1cc2OC(C)(C)Cc2cc1CC(=O)c1cnn2ccc(nc12)C1CCNC1=O
Show InChI InChI=1S/C23H24N4O4/c1-23(2)11-14-8-13(19(30-3)10-20(14)31-23)9-18(28)16-12-25-27-7-5-17(26-21(16)27)15-4-6-24-22(15)29/h5,7-8,10,12,15H,4,6,9,11H2,1-3H3,(H,24,29)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
100n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504184
PNG
(5-Chloro-N-(6-methoxy-2,2- dimethyl-2,3- dihydrobe...)
Show SMILES COc1cc2OC(C)(C)Cc2cc1NC(=O)c1cnn2ccc(Cl)nc12
Show InChI InChI=1S/C18H17ClN4O3/c1-18(2)8-10-6-12(14(25-3)7-13(10)26-18)21-17(24)11-9-20-23-5-4-15(19)22-16(11)23/h4-7,9H,8H2,1-3H3,(H,21,24)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
110n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504207
PNG
((53E,54E)-22,22-Dimethyl-22,23- dihydro-3,6-diaza-...)
Show SMILES CC1(C)Cc2cc3NC(=O)c4cnn5ccc(NCCN6CCN(CC6)c3cc2O1)nc45
Show InChI InChI=1S/C23H27N7O2/c1-23(2)13-15-11-17-18(12-19(15)32-23)29-9-7-28(8-10-29)6-4-24-20-3-5-30-21(27-20)16(14-25-30)22(31)26-17/h3,5,11-12,14H,4,6-10,13H2,1-2H3,(H,24,27)(H,26,31)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
120n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504187
PNG
(US11034698, Example 24 | US11034698, Example 25)
Show SMILES CN1C[C@H](COc2cc3OC(C)(C)Cc3cc2NC(=O)c2cnn3cccnc23)CC1=O
Show InChI InChI=1S/C23H25N5O4/c1-23(2)10-15-8-17(26-22(30)16-11-25-28-6-4-5-24-21(16)28)19(9-18(15)32-23)31-13-14-7-20(29)27(3)12-14/h4-6,8-9,11,14H,7,10,12-13H2,1-3H3,(H,26,30)/t14-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
160n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504200
PNG
(5-(Cyclopropyl(methyl)amino)- N-(6-methoxy-2,2-dim...)
Show SMILES COc1cc2OC(C)(C)Cc2cc1NC(=O)c1cnn2ccc(nc12)N(C)C1CC1
Show InChI InChI=1S/C22H25N5O3/c1-22(2)11-13-9-16(18(29-4)10-17(13)30-22)24-21(28)15-12-23-27-8-7-19(25-20(15)27)26(3)14-5-6-14/h7-10,12,14H,5-6,11H2,1-4H3,(H,24,28)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
180n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM50511353
PNG
(CHEMBL4518564 | US11034698, Example 152)
Show SMILES Cn1ccc2cc(NC(=O)c3cnn4cccnc34)c(cc2c1=O)N1CCOCC1
Show InChI InChI=1S/C21H20N6O3/c1-25-6-3-14-11-17(18(12-15(14)21(25)29)26-7-9-30-10-8-26)24-20(28)16-13-23-27-5-2-4-22-19(16)27/h2-6,11-13H,7-10H2,1H3,(H,24,28)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
210n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504206
PNG
(5-(Dimethylamino)-N-(6- methoxy-2,2-dimethyl-2,3- ...)
Show SMILES COc1cc2OC(C)(C)Cc2cc1NC(=O)c1cnn2ccc(nc12)N(C)C
Show InChI InChI=1S/C20H23N5O3/c1-20(2)10-12-8-14(16(27-5)9-15(12)28-20)22-19(26)13-11-21-25-7-6-17(24(3)4)23-18(13)25/h6-9,11H,10H2,1-5H3,(H,22,26)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
220n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504193
PNG
(US11034698, Example 30 | US11034698, Example 31 | ...)
Show SMILES CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(OC[C@H]3C[C@@H]4NCCO[C@H]4C3)cc2O1
Show InChI InChI=1S/C25H29N5O4/c1-25(2)12-16-10-19(29-24(31)17-13-28-30-6-3-4-27-23(17)30)22(11-20(16)34-25)33-14-15-8-18-21(9-15)32-7-5-26-18/h3-4,6,10-11,13,15,18,21,26H,5,7-9,12,14H2,1-2H3,(H,29,31)/t15-,18-,21-/m0/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
230n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504210
PNG
(N-(1-(3-Hydroxypropyl)-7- morpholino-2-oxo-1,2,3,4...)
Show SMILES OCCCN1C(=O)CCc2cc(NC(=O)c3cnn4cccnc34)c(cc12)N1CCOCC1
Show InChI InChI=1S/C23H26N6O4/c30-10-2-6-28-19-14-20(27-8-11-33-12-9-27)18(13-16(19)3-4-21(28)31)26-23(32)17-15-25-29-7-1-5-24-22(17)29/h1,5,7,13-15,30H,2-4,6,8-12H2,(H,26,32)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
240n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504185
PNG
(US11034698, Example 22 | US11034698, Example 23)
Show SMILES CCN1C[C@H](COc2cc3OC(C)(C)Cc3cc2NC(=O)c2cnn3cccnc23)CC1=O
Show InChI InChI=1S/C24H27N5O4/c1-4-28-13-15(8-21(28)30)14-32-20-10-19-16(11-24(2,3)33-19)9-18(20)27-23(31)17-12-26-29-7-5-6-25-22(17)29/h5-7,9-10,12,15H,4,8,11,13-14H2,1-3H3,(H,27,31)/t15-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
250n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504189
PNG
(US11034698, Example 26 | US11034698, Example 27 | ...)
Show SMILES CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(OC[C@@H]3Cc4ccccc4[C@H]3N)cc2O1
Show InChI InChI=1S/C27H27N5O3/c1-27(2)13-17-11-21(31-26(33)20-14-30-32-9-5-8-29-25(20)32)23(12-22(17)35-27)34-15-18-10-16-6-3-4-7-19(16)24(18)28/h3-9,11-12,14,18,24H,10,13,15,28H2,1-2H3,(H,31,33)/t18-,24-/m0/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
260n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504189
PNG
(US11034698, Example 26 | US11034698, Example 27 | ...)
Show SMILES CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(OC[C@@H]3Cc4ccccc4[C@H]3N)cc2O1
Show InChI InChI=1S/C27H27N5O3/c1-27(2)13-17-11-21(31-26(33)20-14-30-32-9-5-8-29-25(20)32)23(12-22(17)35-27)34-15-18-10-16-6-3-4-7-19(16)24(18)28/h3-9,11-12,14,18,24H,10,13,15,28H2,1-2H3,(H,31,33)/t18-,24-/m0/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
280n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504274
PNG
(N-(7-Morpholino-2,3-dihydro- 1,4-benzoxathiin-6- y...)
Show SMILES O=C(Nc1cc2SCCOc2cc1N1CCOCC1)c1cnn2cccnc12
Show InChI InChI=1S/C19H19N5O3S/c25-19(13-12-21-24-3-1-2-20-18(13)24)22-14-10-17-16(27-8-9-28-17)11-15(14)23-4-6-26-7-5-23/h1-3,10-12H,4-9H2,(H,22,25)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
280n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504242
PNG
(N-[2-[(2R)-2-Fluoro-3-hydroxy- 3-methyl-butyl]-6- ...)
Show SMILES CNc1cc2C(=O)N(C[C@@H](F)C(C)(C)O)Cc2cc1NC(=O)c1cnn2cccnc12
Show InChI InChI=1S/C21H23FN6O3/c1-21(2,31)17(22)11-27-10-12-7-16(15(23-3)8-13(12)20(27)30)26-19(29)14-9-25-28-6-4-5-24-18(14)28/h4-9,17,23,31H,10-11H2,1-3H3,(H,26,29)/t17-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
280n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504277
PNG
(US11034698, Example 156 | US11034698, Example 157)
Show SMILES CN(C)c1cc2[C@H](O)C(C)(C)Cc2cc1NC(=O)c1cnn2cccnc12
Show InChI InChI=1S/C20H23N5O2/c1-20(2)10-12-8-15(16(24(3)4)9-13(12)17(20)26)23-19(27)14-11-22-25-7-5-6-21-18(14)25/h5-9,11,17,26H,10H2,1-4H3,(H,23,27)/t17-/m0/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
310n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504185
PNG
(US11034698, Example 22 | US11034698, Example 23)
Show SMILES CCN1C[C@H](COc2cc3OC(C)(C)Cc3cc2NC(=O)c2cnn3cccnc23)CC1=O
Show InChI InChI=1S/C24H27N5O4/c1-4-28-13-15(8-21(28)30)14-32-20-10-19-16(11-24(2,3)33-19)9-18(20)27-23(31)17-12-26-29-7-5-6-25-22(17)29/h5-7,9-10,12,15H,4,8,11,13-14H2,1-3H3,(H,27,31)/t15-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
460n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504275
PNG
(US11034698, Example 154 | US11034698, Example 155)
Show SMILES CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(cc2[S@]1=O)N1CCOCC1
Show InChI InChI=1S/C21H23N5O3S/c1-21(2)12-14-10-16(17(11-18(14)30(21)28)25-6-8-29-9-7-25)24-20(27)15-13-23-26-5-3-4-22-19(15)26/h3-5,10-11,13H,6-9,12H2,1-2H3,(H,24,27)/t30-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
560n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504189
PNG
(US11034698, Example 26 | US11034698, Example 27 | ...)
Show SMILES CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(OC[C@@H]3Cc4ccccc4[C@H]3N)cc2O1
Show InChI InChI=1S/C27H27N5O3/c1-27(2)13-17-11-21(31-26(33)20-14-30-32-9-5-8-29-25(20)32)23(12-22(17)35-27)34-15-18-10-16-6-3-4-7-19(16)24(18)28/h3-9,11-12,14,18,24H,10,13,15,28H2,1-2H3,(H,31,33)/t18-,24-/m0/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
670n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504193
PNG
(US11034698, Example 30 | US11034698, Example 31 | ...)
Show SMILES CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(OC[C@H]3C[C@@H]4NCCO[C@H]4C3)cc2O1
Show InChI InChI=1S/C25H29N5O4/c1-25(2)12-16-10-19(29-24(31)17-13-28-30-6-3-4-27-23(17)30)22(11-20(16)34-25)33-14-15-8-18-21(9-15)32-7-5-26-18/h3-4,6,10-11,13,15,18,21,26H,5,7-9,12,14H2,1-2H3,(H,29,31)/t15-,18-,21-/m0/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
720n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM504189
PNG
(US11034698, Example 26 | US11034698, Example 27 | ...)
Show SMILES CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(OC[C@@H]3Cc4ccccc4[C@H]3N)cc2O1
Show InChI InChI=1S/C27H27N5O3/c1-27(2)13-17-11-21(31-26(33)20-14-30-32-9-5-8-29-25(20)32)23(12-22(17)35-27)34-15-18-10-16-6-3-4-7-19(16)24(18)28/h3-9,11-12,14,18,24H,10,13,15,28H2,1-2H3,(H,31,33)/t18-,24-/m0/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
780n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma (RORC)


(Homo sapiens (Human))
BDBM480755
PNG
(N-(2,2-dimethyl-6-morpholino- 3H-benzofuran-5-yl)-...)
Show SMILES CC1(C)Cc2cc(NC(=O)c3cnn4ccc(=O)[nH]c34)c(cc2O1)N1CCOCC1
Show InChI InChI=1S/C21H23N5O4/c1-21(2)11-13-9-15(16(10-17(13)30-21)25-5-7-29-8-6-25)23-20(28)14-12-22-26-4-3-18(27)24-19(14)26/h3-4,9-10,12H,5-8,11H2,1-2H3,(H,23,28)(H,24,27)
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
930n/an/an/an/an/an/an/an/a



Genentech, Inc.

US Patent


Assay Description
The IRAK4 reaction conditions were optimized using an IRAK1-derived peptide (sequence H-KKARFSRFAGSSPSQSSMVAR) to provide a linear reaction rate over...


US Patent US11034698 (2021)

More data for this
Ligand-Target Pair
* indicates data uncertainty>20%